The year in review: Updates and trends
In 2022, we witnessed intense activity in matters related to supply chain issues, the energy transition, oil & gas, post-M&A disputes, licensing issues,...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Spotlight
Healthcare Claims Analytics Platform (HCAP)
Healthcare Claims Analytics Platform (HCAP) is a modular, dynamic, rapidly updating data-visualization tool that provides streamlined analysis of patient, Health Care Practitioner (HCP), and Health Care Organization (HCO) level data to support decision making and insight generation. HCAP supports clients in visualizing advanced analytics to provide intelligence on patients, physicians, hospitals, and the broader healthcare market. With the information obtained from HCAP, clients are better informed to make key strategic decisions.
Engagements
- 01AAA dispute involving the scope and breadth of exclusivity of a development deal for monoclonal antibodiesIn an American Arbitration Association (AAA) dispute over early-stage drug candidates in a development agreement between two pharmaceutical companies, CRA...View engagement
- 02CRA experts testify in civil antitrust trial involving alleged tying of PICC lines and location devicesOn October 3, 2022, CRA experts testified on behalf of C.R. Bard in AngioDynamics, Inc. v. C.R. Bard, Inc. et al. in the Northern District of New York....View engagement
- 03CRA experts advise on oncology, consumer health, and animal health transactions before FTCCRA experts advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsRecent events
Inflation Reduction Act – Implications on the biopharmaceutical industry
The Inflation Reduction Act (IRA) was passed into law in August 2022 and is being implemented currently in the US. The moderated panel will be asked to...
3rd Edition Washington Arbitration Week
CRA is a proud sponsor of the event. Peter Rankin presents during the session titled “The Next Variant of International Arbitration: Life Sciences.” Jim...